Litcius/Paper detail

Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)

Hamilton Trinh, Stephen P. Dzul, Jalal Hyder, Hyejeong Jang, Seongho Kim, J. Flowers, Nitin Vaishampayan, Jerry Chen, Ira Winer, Stephen R. Miller

2020Clinica Chimica Acta71 citationsDOI

Topics & Concepts

MedicineLymphocyteInternal medicineChemoradiotherapyCervical cancerNeutrophil to lymphocyte ratioOncologyMonocyteCancerGastroenterologyInflammatory Biomarkers in Disease PrognosisEndometrial and Cervical Cancer TreatmentsImmune cells in cancer
Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT) | Litcius